Clinical Trials on Mixed Dyslipidemias

Total 3910 results

Merck Sharp & Dohme LLC

Completed

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)

Dyslipidemia
Hospital de Clinicas de Porto Alegre

Completed

Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women

Dyslipidemia
Xention Ltd

Completed

TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) (TULIP)

Dyslipidemia

Denmark, Netherlands
University of California, San Diego
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels

Dyslipidemias

United States
China Academy of Chinese Medical Sciences

Completed

A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

Dyslipidemia
New York Hospital Queens
NYHQ Cardiac Health Center; Pivotal Therapeutics

Unknown

An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels (CARE)

Dyslipidemia

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects

Dyslipidemia

Germany
Akros Pharma Inc.

Completed

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
University of Nevada, Las Vegas

Completed

Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia

Dyslipidemia

United States
AstraZeneca

Withdrawn

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes (DEMAND)

Dyslipidemia
AstraZeneca

Completed

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria (CEPHEUS)

Dyslipidemia

Bulgaria
AstraZeneca

Completed

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (RACHEL)

Dyslipidemias
University of Washington
Upsher-Smith Laboratories

Completed

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 (CKD-348)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

Hypertension and Dyslipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Hypertension With Dyslipidemia

Korea, Republic of
Lewai Sharki Abdulaziz, MSc PhD
Al-Kindy College of Medicine

Completed

Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

Atherogenic Dyslipidemia | Obesity Associated Disorder

Iraq
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

Hypertension With Dyslipidemia

Korea, Republic of
University of Pavia
Foundation IRCCS San Matteo Hospital

Recruiting

Effect of the Association of Berberine Fitosoma® and Monacolin K MonaKoPure® on Glyco-metabolic Parameters in Dysglycemic and Dyslipidemic Patients.

Dyslipidemias | Dysglycemia

Italy
Shenzhen Center for Chronic Disease Control
Sun Yat-sen University; Shenzhen Qilinshan Sanatorium

Completed

Micronutrients and Health in Adult Chinese

Dyslipidemia | Dysglycemia
University Medical Centre Ljubljana

Completed

The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

Dyslipidemia | Transplants

Slovenia
University of Rome Tor Vergata

Completed

Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients

Type 2 Diabetes | Diabetic Dyslipidemia

Italy
AstraZeneca
Parexel

Not yet recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia

Cardiovascular

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Cardiovascular Events Based On Statin Initiation In The Elderly

Dyslipidemia | Cardiovascular
IRCCS Policlinico S. Matteo
University of Pavia

Completed

Berberine, Chlorogenic Acid and Tocotrienols in Menopause-associated Dyslipidemia

Dyslipidemia

Italy
AstraZeneca
Parexel

Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia

Cardiovascular

United States
GWT-TUD GmbH

Active, not recruiting

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry (PERI-DYS)

Dyslipoproteinemias

Germany
Gaia AG
University Hospital, Aachen; Deutsche Stiftung für chronisch Kranke

Not yet recruiting

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels (DIGICHOL)

Dyslipidemias | Hypercholesterolemia

Germany
EMS

Recruiting

Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

Dyslipidemia | Hypertriglyceridemia

Brazil
The George Institute for Global Health, China
Ningxia Medical University

Completed

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults (NUTS)

Cardiovascular Diseases | Dyslipidemias

China
Organon and Co

Completed

A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204) (MOBS)

Dyslipidemia | Hypercholesterolemia
Yonsei University

Completed

Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

Dyslipidemias | Hypercholesterolemia

Korea, Republic of
Pfizer

Completed

Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin

Dyslipidemia | Hypercholesterolemia

United States
Casa de Saúde santa Marcelina

Completed

Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial

Dyslipidemias | Menopause | Homocystinaemia
University of Chile
Pontificia Universidad Catolica de Chile

Completed

Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols (ACTICOL)

Dyslipidemias | Hypercholesterolemia

Chile
Wenzhou Medical University

Terminated

The Therapeutic Effects of Statins and Berberine on the Hyperlipemia

Dyslipidemias

China
Pfizer

Withdrawn

Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

Dyslipidemia | Hypercholesterolemia
Abbott

Completed

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Dyslipidemia

Argentina, Czech Republic, Germany, Mexico, Poland, Romania, Russian Federation
Zydus Lifesciences Limited

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Dyslipidemia | Hypertriglyceridemia

India

3

Subscribe